The contract is for the purchase with the delivery of cancer drugs, generic
drugs for hospital pharmacies Holy Cross Cancer Center in Kielce in accordance with:
Total quantity or scope: purchase with the delivery of cancer drugs, generic
drugs for Hospital Pharmacies Holy Cross Cancer Center in Kielce, in accordance with
To calculate the market size, the report considers revenue generated from the sales of branded drugs, generics
, and biosimilars used to treat solid tumors.
Following introductions of generic versions of several large-volume drugs, generics
boosted their share of the network's prescription sales to 57.
Far less expensive to produce than the initial drugs, generics
are often made by the very same companies that produced the original drug.
CP has four key businesses consisting of a branded portfolio of hospital drugs, generics
, contract manufacturing and exports.
Global Pharmaceutical Contract Manufacturing Organization (CMO) Market is part of Frost & Sullivans Life Sciences Growth Partnership Service program, which also includes insights on contract research, biosimilars, orphan drugs, generics
, immuno-oncology therapeutics, regenerative medicines, pharmaceutical regulatory landscape and market access.
With Medicare Part D taking hold, blockbuster drugs going off patent and a rapidly growing elderly population depending on prescription drugs, generics
are poised to account for more than two in three scripts in the U.
While I understand the importance of reviewing and approving new, breakthrough drugs, generics
bring a big bang for the buck.
With today's prescription drugs, generics
companies must demonstrate that their products have the same chemicals and act in the body the same ways as do their brand name equivalents.
And that predicament helps explain why, despite growing apprehension in private and public circles over the escalating price of prescription drugs, generics
-- which can cost as much as 80% less than some branded products -- account for only a little over 40% of all the prescriptions that are dispensed.
The companies have their strategies in place to leverage opportunities and appropriate values existing in formulations, bulk drugs, generics
, Novel Drug Delivery Systems, New Chemical Entities, Biotechnology etc.